Selling into Strength, Buying into Weakness
Update: 2025-09-08
Description
In today's From Theory to Practice, Dr. Jim Schultz noted Best Buy's recovery to $77 and HIMSS rebounding from recent lows around $42 to nearly $50. With CMG and SBUX, Dr. Jim is remaining patient with his long shares position, rather than selling calls against them on weakness.
"I don't want to sell calls when the stock is falling. I want to sell calls on strength," he explained, highlighting his short-term contrarian approach to portfolio management.
"I don't want to sell calls when the stock is falling. I want to sell calls on strength," he explained, highlighting his short-term contrarian approach to portfolio management.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
